B Group, Inc. Diversified Active

CIK: 0002043476 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $116,735 (100.0% shares, 0.0% debt)

Holdings (19)

ADMA ADMA BIOLOGICS INC 39.4%
Value ($000) $45,980 Shares 2,317,542 Est. Cost $18.79 Unrealized -8.0%
INSM INSMED INC 17.2%
Value ($000) $20,026 Shares 262,500 Est. Cost $72.02 Unrealized +6.2%
ZLAB ZAI LAB LTD 12.4%
Value ($000) $14,456 Shares 400,000 Est. Cost $26.19 Unrealized
AKERO THERAPEUTICS INC 8.4%
Value ($000) $9,816 Shares 242,500 Est. Cost $27.82 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.3%
Value ($000) $4,995 Shares 1,500,000 Est. Cost $7.88 Unrealized -34.5%
CLLS CELLECTIS S A 3.5%
Value ($000) $4,038 Shares 3,256,501 Est. Cost $1.77 Unrealized
AURA AURA BIOSCIENCES INC 2.4%
Value ($000) $2,769 Shares 472,576 Est. Cost $9.41 Unrealized -19.6%
SGHT SIGHT SCIENCES INC 1.7%
Value ($000) $2,001 Shares 833,600 Est. Cost $4.13 Unrealized -31.8%
ASMB ASSEMBLY BIOSCIENCES INC 1.6%
Value ($000) $1,912 Shares 200,000 Est. Cost $13.84 Unrealized -5.5%
TSHA TAYSHA GENE THERAPIES INC 1.5%
Value ($000) $1,745 Shares 1,255,556 Est. Cost $1.98 Unrealized -15.6%
RARE ULTRAGENYX PHARMACEUTICAL IN 1.5%
Value ($000) $1,720 Shares 47,500 Est. Cost $42.88 Unrealized -3.0%
BNTX BIONTECH SE 1.2%
Value ($000) $1,366 Shares 15,000 Est. Cost $96.40 Unrealized
ULTRAGENYX PHARMACEUTICAL IN 1.2%
Value ($000) $1,361 Shares 37,600 Est. Cost $42.07 Unrealized
SYRE SPYRE THERAPEUTICS INC 1.0%
Value ($000) $1,129 Shares 70,000 Est. Cost $26.89 Unrealized -22.6%
APGE APOGEE THERAPEUTICS INC 1.0%
Value ($000) $1,121 Shares 30,000 Est. Cost $44.83 Unrealized -13.8%
PRAX PRAXIS PRECISION MEDICINES I 0.6%
Value ($000) $720 Shares 19,000 Est. Cost $62.45 Unrealized 0.0%
89BIO INC 0.6%
Value ($000) $695 Shares 95,623 Est. Cost $7.27 Unrealized
ORKA ORUKA THERAPEUTICS INC 0.5%
Value ($000) $597 Shares 58,215 Est. Cost $16.57 Unrealized -24.7%
CORVUS PHARMACEUTICALS INC 0.2%
Value ($000) $286 Shares 90,000 Est. Cost $5.35 Unrealized